Baku, Azerbaijan
Baku, Azerbaijan
Baku, Azerbaijan
Molecular modeling methods were used to study the features of the spatial and electronic structure of the antitumor tripeptide YSL (Tyr-Ser-Leu), developed by Chinese scientists. The conformational analysis of the molecule revealed a limited set of its energetically preferable conformational states in a certain range of relative energy. The nature of the forces stabilizing the low-energy conformations of the tripeptide molecule was determined. As a result of the study, the energetically preferable ranges of dihedral angles, the energy contributions of interresidual interactions and hydrogen bonds, as well as the mutual arrangement of residues and their side chains in low-energy conformations of the tripeptide were also determined. Using the methods of molecular mechanics, the energy contributions of intramolecular interactions in low-energy conformational states of the molecule were obtained. Based on quantum-chemical calculations, the distribution of electron density and the values of dipole moments of the most optimal spatial structures of the YSL tripeptide molecule were determined. The reactivity of the tripeptide was also studied by quantum chemical calculations based on the obtained electronic characteristics of each low-energy conformation of the molecule. Using the calculated coordinates of the atoms of the energetically preferable structures of the molecule, their molecular models were built, the comparison of which makes it possible to identify the structural criteria necessary to create a drug suitable for clinical use.
antitumor agent, tripeptide, conformation, molecular mechanics method, quant-chemical calculations
1. Wang C., Wang S., Lu R., Zhao L., Zhu Z.F., Xu Q., Lv J.Q., Wang L.L., Fu Z., Lin G., Yao Z. Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma. Anticancer Drugs, 2009, vol. 20, no. 7, pp. 534-42, doi:https://doi.org/10.1097/CAD.0b013e32832ced93.
2. Wang H.Y., Yi W.J., Qin S.Y., Li C., Zhuo R.X., Zhang X.Z. Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy. Biomaterials, 2012, vol. 33, no. 33, pp. 8685-8694, doi:https://doi.org/10.1016/j.Biomaterials.2012.08.022.
3. Fu Z., Lu R., Li G., Zhao L., Gao W., Che X., Jian X., Zhou C., Yao Z. Tyroserleutide tripeptide affects calcium homeostasis of human hepatocarcinoma BEL-7402 cells. Sci. China C Life Sci., 2005, vol. 48, no. 5, pp. 523-530.
4. Lu R., Jia J., Bao L., Fu Z., Li G., Wang S., Wang Z., Jin M., Gao W., Yao Z. Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL). Cancer Chemother. Pharmacol., 2006, vol. 57, no. 2, pp. 248-256.
5. Ding W., Zhang J., Yao Z., Lu R., Wu D., Li G., Shen Z., Sun Y., Lin G., Wang C., Zhao M., Peng S. The synthesis, distribution, and anti-hepatic cancer activity of YSL. Bioorg Med Chem., 2004, vol. 12, no. 18, pp. 4989-4994.
6. Agaeva G.A., Agaeva U.T., Gojaev N.M. Features of the spatial organization of human hemokinin-1 and mouse/rat hemokinin-1 molecules. Biophysics, 2015, vol. 60, iss. 3, pp. 457-470 (In Russ.).
7. IUPAC-IUB Commision on Biochemical Nomenclature Abbreviations and symbols for description of conformation of polypeptide chains. Pure Appl. Chem., 1974, vol. 40, pp. 291-308.
8. Maksumov I.S., Ismailova L.I., Gojaev N.M. The program of semi-empirical calculation of conformations of molecular complexes on a computer. Journal of Structural Chemistry, vol. 24, no. 4, 1983, pp. 147-148 (In Russ.).
9. Chem 3D Pro, “Molecular Modeling and Analysis”, Cambridge Soft Corporation, 875 Massachusetts, 02139 U.S.A (2005)
